230 related articles for article (PubMed ID: 25774822)
21. Evaluation of Long-Term Clinical Outcomes and Patient Satisfaction Rate Following Low Intensity Shock Wave Therapy in Men With Erectile Dysfunction: A Minimum 5-Year Follow-Up on a Prospective Open-Label Single-Arm Clinical Study.
Chung E; Cartmill R
Sex Med; 2021 Aug; 9(4):100384. PubMed ID: 34126432
[TBL] [Abstract][Full Text] [Related]
22. Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis.
Lu Z; Lin G; Reed-Maldonado A; Wang C; Lee YC; Lue TF
Eur Urol; 2017 Feb; 71(2):223-233. PubMed ID: 27321373
[TBL] [Abstract][Full Text] [Related]
23. A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction.
Rubio-Aurioles E; Reyes LA; Borregales L; Cairoli C; Sorsaburu S
Curr Med Res Opin; 2013 Jun; 29(6):695-706. PubMed ID: 23540375
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
Paick JS; Ahn TY; Choi HK; Chung WS; Kim JJ; Kim SC; Kim SW; Lee SW; Min KS; Moon KH; Park JK; Park K; Park NC; Suh JK; Yang DY; Jung HG
J Sex Med; 2008 Nov; 5(11):2672-80. PubMed ID: 18638004
[TBL] [Abstract][Full Text] [Related]
25. A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction.
Chung E; Wang J
Expert Rev Med Devices; 2017 Dec; 14(12):929-934. PubMed ID: 29119841
[TBL] [Abstract][Full Text] [Related]
26. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.
Moon du G; Yang DY; Lee CH; Ahn TY; Min KS; Park K; Park JK; Kim JJ
J Sex Med; 2011 Jul; 8(7):2048-61. PubMed ID: 21554549
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction.
Ruffo A; Capece M; Prezioso D; Romeo G; Illiano E; Romis L; Di Lauro G; Iacono F
Int Braz J Urol; 2015; 41(5):967-74. PubMed ID: 26689523
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy of penile rehabilitation with low-intensity extracorporeal shock wave therapy for sexual and erectile function recovery following robotic-assisted radical prostatectomy: a single-cohort pilot study.
Kohada Y; Babasaki T; Goto K; Inoue S; Kurimura Y; Tasaka R; Takemoto K; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Hieda K; Hayashi T; Hinata N
Sex Med; 2023 Apr; 11(2):qfad023. PubMed ID: 37228769
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails.
Lee M; Sharifi R
Drugs Aging; 2018 Mar; 35(3):175-187. PubMed ID: 29464656
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of mirodenafil in men taking antihypertensive medications.
Paick JS; Kim JJ; Kim SC; Moon KH; Min KS; Park K; Suh JK; Yang DY
J Sex Med; 2010 Sep; 7(9):3143-52. PubMed ID: 20649936
[TBL] [Abstract][Full Text] [Related]
31. Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study.
Olsen AB; Persiani M; Boie S; Hanna M; Lund L
Scand J Urol; 2015; 49(4):329-33. PubMed ID: 25470423
[TBL] [Abstract][Full Text] [Related]
32. [Low-intensity shock wave therapy for erectile dysfunction: Progression in application].
Cheng C; Dong ZL; Wang ZP
Zhonghua Nan Ke Xue; 2018 Janurary; 24(1):78-81. PubMed ID: 30157366
[TBL] [Abstract][Full Text] [Related]
33. Low-intensity shockwave treatment (LISWT) improves penile rigidity in eugonadal subjects with erectile dysfunction: a pilot study.
Vena W; Vaccalluzzo L; LA Vignera S; Morenghi E; D'Agostino C; Perri A; Giammusso B; Lania AG; Aversa A; Pizzocaro A
Minerva Endocrinol (Torino); 2023 Mar; 48(1):4-11. PubMed ID: 34931511
[TBL] [Abstract][Full Text] [Related]
34. Physical activity and PDE5 inhibitors in the treatment of erectile dysfunction: results of a randomized controlled study.
Maio G; Saraeb S; Marchiori A
J Sex Med; 2010 Jun; 7(6):2201-2208. PubMed ID: 20367777
[TBL] [Abstract][Full Text] [Related]
35. Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study.
Reisman Y; Hind A; Varaneckas A; Motil I
Int J Impot Res; 2015; 27(3):108-12. PubMed ID: 25471316
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
[TBL] [Abstract][Full Text] [Related]
37. Satisfaction profiles in men using intracavernosal injection therapy.
Hsiao W; Bennett N; Guhring P; Narus J; Mulhall JP
J Sex Med; 2011 Feb; 8(2):512-7. PubMed ID: 21054797
[TBL] [Abstract][Full Text] [Related]
38. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction.
Labairu-Huerta L; Padilla-Fernández B; Arrondo-Arrondo JL; Valverde-Martínez LS; Martín-Rodríguez A; Silva-Abuín JM; García-Cenador MB; Mirón-Canelo JA; Lorenzo-Gómez MF
Arch Ital Urol Androl; 2015 Sep; 87(3):204-9. PubMed ID: 26428641
[TBL] [Abstract][Full Text] [Related]
39. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.
Goldfischer ER; Kim ED; Seftel AD; Baygani SK; Burns PR
Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311
[TBL] [Abstract][Full Text] [Related]
40. [Vacuum therapy for erectile dysfunction that fails to respond to PDE-5i: report of 70 cases].
Li P; Shen YJ; Liu TQ; Ma M; Zhang SJ; Wang YX; Tian RH; Chen HX; Ping P; Chen XF; Li Z; Li Z
Zhonghua Nan Ke Xue; 2013 Mar; 19(3):236-40. PubMed ID: 23700730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
